olaparib,177Lu-PSMA-617
novartis,merck,astrazeneca
['psma-617 ', 'olaparib']
lu-psma-617 in combination with olaparib is well tolerated #asco2023 #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.